Chronic News and Research

RSS

Scientists suggest targeting ion channels could offer effective pain relief

University at Buffalo neuroscience researchers conducting basic research on ion channels have demonstrated a process that could have a profound therapeutic impact on pain.

20 Dec 2010

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Cystic fibrosis patients with normal to mildly impaired lung function may benefit from a new investigational drug designed to help prevent formation of the sticky mucus that is a hallmark of the disease, according to researchers involved in a phase 3 clinical trial of the drug.

19 Dec 2010

UCLA report: Low-income Californians with asthma experience more frequent symptoms

Almost 5 million Californians have been diagnosed with asthma, and those living in poverty suffer more severe consequences from the condition than those in higher income brackets, according to a new report from the UCLA Center for Health Policy Research.

17 Dec 2010

First comprehensive textbook on psychology for medical students

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies. Following the General Medical Council's call for greater coverage of psychology throughout medical degree courses, this groundbreaking textbook does just that - presenting all the psychology an undergraduate medical student needs to know.

17 Dec 2010

Tips to enjoy holiday food and other special parts of the season

While most of us look forward with anticipation to the culinary delights of the holiday season, the decedent buffet can be treacherous territory for those with food-related health concerns.

17 Dec 2010

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

Amanda Freitag, celebrity chef and recurring judge on the Food Network's "Chopped," and Julie Barto, a registered dietitian specializing in multiple sclerosis, have teamed up to create a nutrition program especially for people with MS.

17 Dec 2010

Health inequalities still exist between England's richest and poorest

Significant health inequalities still exist between the country's richest and poorest according to the latest findings from the biggest annual survey of health in England, The Health Survey for England. The survey, conducted by the National Centre for Social Research and UCL and funded by The NHS Information Centre, shows that people in the lowest income households continue to experience much worse outcomes across key health measures than people in the highest income households.

17 Dec 2010

Prions responsible for BSE can survive in new host environment

Scientists from the Florida campus of The Scripps Research Institute have shown that prions, bits of infectious protein that can cause fatal neurodegenerative disease such as bovine spongiform encephalopathy or "mad cow disease," have the ability to adapt to survive in a new host environment.

17 Dec 2010

Study suggests blood test may detect persons with CKD

An infrequently used blood test can effectively identify individuals at increased risk of developing complications associated with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

17 Dec 2010

Bayer's SAFYRAL oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.

17 Dec 2010

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.

17 Dec 2010

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Naturally occurring high hemoglobin levels are safe for kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

17 Dec 2010

Study reveals immune cell provides new therapeutic strategy for SLE

A new study provides fascinating insight into the underlying pathology associated with the autoimmune disease, systemic lupus erythematosus.

16 Dec 2010

Gene variant linked to liver cirrhosis in Caucasians

A new study by German researchers found that a variation in the PNPLA3 (adiponutrin) gene was associated with cirrhosis of the liver and elevated transaminase (liver enzyme) levels in alcoholic Caucasians. The risk of cirrhosis in alcoholics in the genetic high risk group might be as high as 25 to 50%. Full findings are published in the January 2011 issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

16 Dec 2010

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.

16 Dec 2010

Gene variation linked to liver cirrhosis in alcoholic caucasians

16 Dec 2010

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

The non-profit MedicAlert Foundation published a "Code of Conduct" in an effort to help consumers evaluate the integrity of organizations providing emergency medical information and identification services. In addition, as part of the "Code of Conduct" the Foundation has established business practice standards for medical information and identification service organizations that house consumer health information. Across the country millions of consumers are using personal health records, emergency medical information services, personal medical alarms systems or medical identification jewelry services.

16 Dec 2010

Determinants of health have stronger impact on Canadians' health than healthy lifestyle

A report released today by the Health Council of Canada declares that unless governments change their approach to addressing the needs of poorer and socially disadvantaged Canadians, we are destined to continue to spend large amount of dollars on our health care system. Governments must expand their approach to health promotion in order to tackle the major societal factors that lead to poor health and to take pressure off health care budgets.

16 Dec 2010

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Oxygen Biotherapeutics, Inc. and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today announced they signed a Binding Letter of Intent to determine the feasibility of pursuing a joint research and development venture for treating chronic ischemic wounds. The venture will be based on combining Oxygen's Wundecyte™ PFC formulation with SMP's topical medical devices.

16 Dec 2010

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.

16 Dec 2010

Chronic News and Research

Scientists suggest targeting ion channels could offer effective pain relief

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

UCLA report: Low-income Californians with asthma experience more frequent symptoms

First comprehensive textbook on psychology for medical students

Tips to enjoy holiday food and other special parts of the season

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

Health inequalities still exist between England's richest and poorest

Prions responsible for BSE can survive in new host environment

Study suggests blood test may detect persons with CKD

Bayer's SAFYRAL oral contraceptive receives FDA approval

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Study reveals immune cell provides new therapeutic strategy for SLE

Gene variant linked to liver cirrhosis in Caucasians

Guardian 24/7 selects Glowpoint's video managed services for remote diagnosis and patient collaboration

Gene variation linked to liver cirrhosis in alcoholic caucasians

MedicAlert Foundation's 'Code of Conduct' helps evaluate integrity of emergency medical information

Determinants of health have stronger impact on Canadians' health than healthy lifestyle

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News